Topical nitrogen mustard for the treatment of granulomatous slack skin

Potential of B24O24 nanocluster for sensing and delivering chlormethine anticancer drug: a DFT study

In the present research, the adsorption and release of chlormethine (CM) drug on the B₂₄O₂₄ nanocage have been reported in the water media and gas phase at GGA/PBE/DNP computational level. The interaction between B₂₄O₂₄ nanocage and CM drug shows that adsorptions of the chlormethine on B₂₄O₂₄ nanocage for the most stable complexes are - 1.47 to - 1.36 eV in the gas phase and water media, respectively. The CM adsorption caused a notable change in the band gap (E_g) and work function (Φ) of the B₂₄O₂₄ nanocage in the studied complexes. The binding of chlormethine to B₂₄O₂₄ also significantly increased the polarity of the drug carrier, which is a desirable property for drug delivery in biological environments. CM drugs can be released from the nanocage in the presence of an external electric field along the X-axis direction. The present study results show that the B₂₄O₂₄ nanocage is a possible carrier for delivering chlormethine drugs.

Cutaneous T Cell Lymphoma: A Difficult Diagnosis Demystified

Cutaneous T cell lymphoma (CTCL) represents a heterogeneous group of extranodal non-Hodgkin lymphomas in which monoclonal T lymphocytes infiltrate the skin. The mechanism of CTCL development is not fully understood, but likely involves dysregulation of various genes and signaling pathways. A variety of treatment modalities are available, and although they can induce remission in most patients, the disease may recur after treatment cessation. Owing to relatively low incidence and significant chronicity of disease, and the high morbidity of some therapeutic regimens, further clinical trials are warranted to better define the ideal treatment option for each subtype of CTCL.